Age-dependent determinants of infectious complications profile in children and adults after hematopoietic cell transplantation: lesson from the nationwide studyLidia Gil, Jarosław Dybko, Kazimierz Hałaburda et al.|Annals of Hematology|2019Cited by 49
Efficacy and toxicity of compassionate ibrutinib use in relapsed/refractory chronic lymphocytic leukemia in Poland: analysis of the Polish Adult Leukemia Group (PALG)Elżbieta Iskierka‐Jazdzewska, Krzysztof Jamroziak, Jan Maciej Zaucha et al.|Leukemia & lymphoma/Leukemia and lymphoma|2017Cited by 39
Imatinib mesylate may induce long-term clinical response in FIP1L1-PDGFRα-negative hypereosinophilic syndromeGrzegorz Helbig, Sławomira Kyrcz‐Krzemień, Małgorzata Stachowicz et al.|Medical Oncology|2011Cited by 28
Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemiaGrzegorz Helbig, Sławomira Kyrcz‐Krzemień, Ilona Seferyńska et al.|Cancer Chemotherapy and Pharmacology|2011Cited by 24
Clinical characteristics of patients with chronic eosinophilic leukaemia (CEL) harbouring FIP1L1‐PDGFRA fusion transcript—results of Polish multicentre studyGrzegorz Helbig, Sławomira Kyrcz‐Krzemień, Alina Świderska et al.|Hematological Oncology|2009Cited by 23